参考文献/References:
[1] Osteoporosis prevention, diagnosis, and therapy[J].NIH Consens Statement,2000,17(1):1-45.
[2] Alexandre C, Vico L. Pathophysiology of bone loss in disuse osteoporosis[J].Joint Bone Spine,2011,78(6):572-576. DOI:10.1016/j.jbspin.2011.04.007.
[3] Takata S, Yasui N. Disuse osteoporosis[J].J Med Invest,2001,48(3-4):147-156.
[4] Lieben L, Callewaert F, Bouillon R. Bone and metabolism: a complex crosstalk[J].Horm Res,2009,71(Suppl 1):134-138. DOI:10.1159/000178056.
[5] Edwards WB, Schnitzer TJ, Troy KL. Reduction in proximal femoral strength in patients with acute spinal cord injury[J].J Bone Miner Res,2014,29(9):2074-2079. DOI:10.1002/jbmr.2227.
[6] Gibon E, Lu L, Goodman SB. Aging, inflammation, stem cells, and bone healing[J].Stem Cell Res Ther,2016,7:44. DOI:10.1186/s13287-016-0300-9.
[7] Nakashima T. Frontiers in live bone imaging researches. Amazing function of osteocyte[J].Clin Calcium,2015,25(6):899-905. DOI:CliCa1506899905.
[8] Bikle DD, Halloran BP, Morey-Holton E. Spaceflight and the skeleton: lessons for the earthbound[J].Gravit Space Biol Bull,1997,10(2):119-135.
[9] Mutijima E, De Maertelaer V, Deprez M,et al. The apoptosis of osteoblasts and osteocytes in femoral head osteonecrosis: its specificity and its distribution[J].Clin Rheumatol,2014,33(12):1791-1795. DOI:10.1007/s10067-014-2607-1.
[10] Howe TE, Shea B, Dawson LJ,et al. Exercise for preventing and treating osteoporosis in postmenopausal women[J].Cochrane Database Syst Rev,2011,(7):CD000333. DOI:10.1002/14651858.CD000333.pub2.
[11] Amigues I, Schott AM, Amine M,et al. Low skeletal muscle mass and risk of functional decline in elderly community-dwelling women: the prospective EPIDOS study[J].J Am Med Dir Assoc,2013,14(5):352-357. DOI:10.1016/j.jamda.2012.12.002.
[12] Moriishi T, Fukuyama R, Ito M,et al. Osteocyte network; a negative regulatory system for bone mass augmented by the induction of Rankl in osteoblasts and Sost in osteocytes at unloading[J].PLoS One,2012,7(6):e40143. DOI:10.1371/journal.pone.0040143.
[13] Boyce BF, Rosenberg E, de Papp AE,et al. The osteoclast, bone remodelling and treatment of metabolic bone disease[J].Eur J Clin Invest,2012,42(12):1332-1341. DOI:10.1111/j.1365-2362.2012.02717.x.
[14] Gaudio A, Pennisi P, Bratengeier C,et al. Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss[J].J Clin Endocrinol Metab,2010,95(5):2248-2253. DOI:10.1210/jc.2010-0067.
[15] Tsushima H, Okazaki K, Ishihara K,et al. CCAAT/enhancer-binding protein β promotes receptor activator of nuclear factor-kappa-B ligand(RANKL)expression and osteoclast formation in the synovium inrheumatoid arthritis[J].Arthritis Res Ther,2015,17:31. DOI:10.1186/s13075-015-0532-6.
[16] Klein-Nulend J, van der Plas A, Semeins CM,et al. Sensitivity of osteocytes to biomechanical stress in vitro[J].FASEB J,1995,9(5):441-445.
[17] Cavaliver E, Souberbielle JC, Gadisseur R, et al. Inter-method variability in bone alkaline phosphatase measurement: chinical impact on the management of dialysis patients[J]. Clin Biochem, 2014, 47(13-14):1227-1230.DOI:10.1016/j.clinbiochem.2014.04.007.